219 related articles for article (PubMed ID: 23647006)
1. Indications and safety of proton pump inhibitor drug use in patients with cancer.
Triadafilopoulos G; Roorda AK; Akiyama J
Expert Opin Drug Saf; 2013 Sep; 12(5):659-72. PubMed ID: 23647006
[TBL] [Abstract][Full Text] [Related]
2. Considerations for the use of proton-pump inhibitors in older adults.
Desilets AR; Asal NJ; Dunican KC
Consult Pharm; 2012 Feb; 27(2):114-20. PubMed ID: 22330952
[TBL] [Abstract][Full Text] [Related]
3. Proton pump inhibitors: potential adverse effects.
Abraham NS
Curr Opin Gastroenterol; 2012 Nov; 28(6):615-20. PubMed ID: 23010681
[TBL] [Abstract][Full Text] [Related]
4. Long-term acid inhibition: benefits and harms.
Tepeš B
Dig Dis; 2011; 29(5):476-81. PubMed ID: 22095013
[TBL] [Abstract][Full Text] [Related]
5. Recent safety concerns with proton pump inhibitors.
Chen J; Yuan YC; Leontiadis GI; Howden CW
J Clin Gastroenterol; 2012 Feb; 46(2):93-114. PubMed ID: 22227731
[TBL] [Abstract][Full Text] [Related]
6. [Adverse events associated with long-term use of proton pump inhibitors].
Reimer C; Bytzer P
Ugeskr Laeger; 2012 Sep; 174(39):2289-93. PubMed ID: 23006222
[TBL] [Abstract][Full Text] [Related]
7. The relationship among proton pump inhibitors, bone disease and fracture.
Targownik LE; Leslie WD
Expert Opin Drug Saf; 2011 Nov; 10(6):901-12. PubMed ID: 21599546
[TBL] [Abstract][Full Text] [Related]
8. Perils and pitfalls of long-term effects of proton pump inhibitors.
Wilhelm SM; Rjater RG; Kale-Pradhan PB
Expert Rev Clin Pharmacol; 2013 Jul; 6(4):443-51. PubMed ID: 23927671
[TBL] [Abstract][Full Text] [Related]
9. Proton pump inhibitors and histamine-2 receptor antagonists in the intensive care setting: focus on therapeutic and adverse events.
MacLaren R; Kassel LE; Kiser TH; Fish DN
Expert Opin Drug Saf; 2015 Feb; 14(2):269-80. PubMed ID: 25423448
[TBL] [Abstract][Full Text] [Related]
10. Risk of community-acquired pneumonia in veteran patients to whom proton pump inhibitors were dispensed.
Hermos JA; Young MM; Fonda JR; Gagnon DR; Fiore LD; Lawler EV
Clin Infect Dis; 2012 Jan; 54(1):33-42. PubMed ID: 22100573
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness and safety of proton pump inhibitors in infantile gastroesophageal reflux disease.
Higginbotham TW
Ann Pharmacother; 2010 Mar; 44(3):572-6. PubMed ID: 20124466
[TBL] [Abstract][Full Text] [Related]
12. Proton pump inhibitor therapy predisposes to community-acquired Streptococcus pneumoniae pneumonia.
de Jager CP; Wever PC; Gemen EF; van Oijen MG; van Gageldonk-Lafeber AB; Siersema PD; Kusters GC; Laheij RJ
Aliment Pharmacol Ther; 2012 Nov; 36(10):941-9. PubMed ID: 23034135
[TBL] [Abstract][Full Text] [Related]
13. No consistent evidence of differential cardiovascular risk amongst proton-pump inhibitors when used with clopidogrel: meta-analysis.
Kwok CS; Jeevanantham V; Dawn B; Loke YK
Int J Cardiol; 2013 Aug; 167(3):965-74. PubMed ID: 22464478
[TBL] [Abstract][Full Text] [Related]
14. Proton pump inhibitors, adverse events and increased risk of mortality.
Lanas-Gimeno A; Hijos G; Lanas Á
Expert Opin Drug Saf; 2019 Nov; 18(11):1043-1053. PubMed ID: 31498687
[No Abstract] [Full Text] [Related]
15. Are proton pump inhibitors associated with the development of community-acquired pneumonia? A meta-analysis.
Giuliano C; Wilhelm SM; Kale-Pradhan PB
Expert Rev Clin Pharmacol; 2012 May; 5(3):337-44. PubMed ID: 22697595
[TBL] [Abstract][Full Text] [Related]
16. Proton pump inhibitor use and association with spontaneous bacterial peritonitis in patients with cirrhosis and ascites.
Siple JF; Morey JM; Gutman TE; Weinberg KL; Collins PD
Ann Pharmacother; 2012 Oct; 46(10):1413-8. PubMed ID: 23032651
[TBL] [Abstract][Full Text] [Related]
17. Inconsistencies surrounding the risk of adverse outcomes with concomitant use of clopidogrel and proton pump inhibitors.
Kwok CS; Loke YK
Expert Opin Drug Saf; 2012 Mar; 11(2):275-84. PubMed ID: 22288498
[TBL] [Abstract][Full Text] [Related]
18. Proton Pump Inhibitors and the Risk for Hospital-Acquired Clostridium difficile Infection.
Barletta JF; El-Ibiary SY; Davis LE; Nguyen B; Raney CR
Mayo Clin Proc; 2013 Oct; 88(10):1085-90. PubMed ID: 24012413
[TBL] [Abstract][Full Text] [Related]
19. Proton Pump Inhibitors: Risks and Rewards and Emerging Consequences to the Gut Microbiome.
Singh A; Cresci GA; Kirby DF
Nutr Clin Pract; 2018 Oct; 33(5):614-624. PubMed ID: 30071147
[TBL] [Abstract][Full Text] [Related]
20. Proton-pump inhibitors adverse effects: a review of the evidence and position statement by the Sociedad Española de Patología Digestiva.
de la Coba Ortiz C; Argüelles Arias F; Martín de Argila de Prados C; Júdez Gutiérrez J; Linares Rodríguez A; Ortega Alonso A; Rodríguez de Santiago E; Rodríguez-Téllez M; Vera Mendoza MI; Aguilera Castro L; Álvarez Sánchez Á; Andrade Bellido RJ; Bao Pérez F; Castro Fernández M; Giganto Tomé F
Rev Esp Enferm Dig; 2016 Apr; 108(4):207-24. PubMed ID: 27034082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
